FR2644697B1 - Composes anesthesiques a duree d'action controlee et compositions pharmaceutiques les contenant - Google Patents

Composes anesthesiques a duree d'action controlee et compositions pharmaceutiques les contenant

Info

Publication number
FR2644697B1
FR2644697B1 FR8903909A FR8903909A FR2644697B1 FR 2644697 B1 FR2644697 B1 FR 2644697B1 FR 8903909 A FR8903909 A FR 8903909A FR 8903909 A FR8903909 A FR 8903909A FR 2644697 B1 FR2644697 B1 FR 2644697B1
Authority
FR
France
Prior art keywords
action
pharmaceutical compositions
compositions containing
controlled duration
anesthetic compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8903909A
Other languages
English (en)
Other versions
FR2644697A1 (fr
Inventor
Serge Raynal
Maryse Grousset
Alain Rancurel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMACIENCE LABORATOIRES
Societe Nationale des Poudres et Explosifs
Original Assignee
PHARMACIENCE LABORATOIRES
Societe Nationale des Poudres et Explosifs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMACIENCE LABORATOIRES, Societe Nationale des Poudres et Explosifs filed Critical PHARMACIENCE LABORATOIRES
Priority to FR8903909A priority Critical patent/FR2644697B1/fr
Priority to PCT/FR1990/000197 priority patent/WO1990011292A2/fr
Priority to EP19900905561 priority patent/EP0418365A1/fr
Publication of FR2644697A1 publication Critical patent/FR2644697A1/fr
Application granted granted Critical
Publication of FR2644697B1 publication Critical patent/FR2644697B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR8903909A 1989-03-24 1989-03-24 Composes anesthesiques a duree d'action controlee et compositions pharmaceutiques les contenant Expired - Lifetime FR2644697B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR8903909A FR2644697B1 (fr) 1989-03-24 1989-03-24 Composes anesthesiques a duree d'action controlee et compositions pharmaceutiques les contenant
PCT/FR1990/000197 WO1990011292A2 (fr) 1989-03-24 1990-03-23 Composes anesthesiques a duree d'action controlee et compositions pharmaceutiques les contenant
EP19900905561 EP0418365A1 (fr) 1989-03-24 1990-03-23 Composes anesthesiques a duree d'action controlee et compositions pharmaceutiques les contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903909A FR2644697B1 (fr) 1989-03-24 1989-03-24 Composes anesthesiques a duree d'action controlee et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
FR2644697A1 FR2644697A1 (fr) 1990-09-28
FR2644697B1 true FR2644697B1 (fr) 1992-05-15

Family

ID=9380039

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8903909A Expired - Lifetime FR2644697B1 (fr) 1989-03-24 1989-03-24 Composes anesthesiques a duree d'action controlee et compositions pharmaceutiques les contenant

Country Status (3)

Country Link
EP (1) EP0418365A1 (fr)
FR (1) FR2644697B1 (fr)
WO (1) WO1990011292A2 (fr)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB665675A (en) * 1948-12-02 1952-01-30 Ward Blenkinsop & Co Ltd Process for the manufacture of derivatives of hydroxy acids
US2891091A (en) * 1957-06-03 1959-06-16 Canadian Patents Dev Derivatives of para-aminosalicylic acid
FR1553098A (fr) * 1967-11-30 1969-01-10
AT331994B (de) * 1972-12-05 1976-09-10 Boehringer Mannheim Gmbh Verfahren zur bestimmung von delta-glutamyltranspeptidase
CA1087075A (fr) * 1977-08-05 1980-10-07 Robert J. Gargiulo Produit et methode de dosage de l'activite de la transferase et de la protease
JPS54157691A (en) * 1978-06-01 1979-12-12 Nitto Boseki Co Ltd Novel substrate for measuring enzyme activity
JPS5569549A (en) * 1978-11-16 1980-05-26 Nitto Boseki Co Ltd Novel substrate for determination of enzyme activity
JPS58172354A (ja) * 1982-04-05 1983-10-11 Dai Ichi Pure Chem Co Ltd ペプチド誘導体
DE3244030A1 (de) * 1982-11-27 1984-05-30 Behringwerke Ag, 3550 Marburg Chromogene verbindungen, verfahren zu ihrer herstellung und ihre verwendung
ATE39245T1 (de) * 1983-02-03 1988-12-15 Univ California Beta-adrenergisch antagonistische verbindungen und derivate von beta-adrenergischen antagonisten.
DE3428543A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue p-phenylendiamin-peptide und diese enthaltende reagenzien zur bestimmung von proteasen des blutgerinnungssystems
DE3668450D1 (de) * 1985-03-14 1990-03-01 Smithkline Dauelsberg 5-aminosalicylsaeurederivate von nicht-steroidalen entzuendungshemmenden sauren.

Also Published As

Publication number Publication date
WO1990011292A2 (fr) 1990-10-04
EP0418365A1 (fr) 1991-03-27
FR2644697A1 (fr) 1990-09-28
WO1990011292A3 (fr) 1990-11-15

Similar Documents

Publication Publication Date Title
FR2596758B1 (fr) Sels pharmaceutiques d'amlodipine ameliores et compositions pharmaceutiques les contenant
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
PT87492A (pt) Process for the preparation of benzo ]b" pyrrans and pyranopyridines and pharmaceutical compositions containing them
FR2581548B1 (fr) Dispositif d'injection intraosseuse de produits biocompatibles
FR2608427B1 (fr) Hydrosols de substances pharmacologiquement actives et compositions pharmaceutiques les contenant
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
FR2626002B1 (fr) Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant
FR2645152B1 (fr) 3h-pteridinones-4, procedes de preparation et medicaments les contenant
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
FR2567510B1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
PH24326A (en) Substituted 3,4-dihydro-2h-benzopyrans,pharmaceutical compositions containing same and method of use thereof
FR2626175B1 (fr) Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant
MC1847A1 (fr) Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant
MA20015A1 (fr) Composes de la benzoyluree et compositions pesticides et pharmaceutiques les contenant
FR2533919B1 (fr) Derives a activite biologique de la 2,5-piperazinedione, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2618333B1 (fr) Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
FR2532309B1 (fr) Perfluorocycloamines et preparation d'emulsions therapeutiques contenant ces perfluorocycloamines
FR2640269B1 (fr) Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant
MA20012A1 (fr) Composes de la benzoluree et compositions pesticides et pharmaceutiques les contenant
FR2634764B1 (fr) Heterocycles oxaza et compositions pharmaceutiques les contenant
FR2644697B1 (fr) Composes anesthesiques a duree d'action controlee et compositions pharmaceutiques les contenant
FR2620450B1 (fr) Nouveaux sels de composes organogermaniques et medicaments les contenant
FR2515038B1 (fr) A titre de medicaments, certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant
FR2636947B1 (fr) Composes de pyrrolidinone et de piperidinone et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20051130